Clinical trial Recruiting at 7 sites Interventional Ages 40 to 69

Innovative approaches for personalized cardiovascular prevention

Official title: Feasibility of InnovaTive Approaches for Personalized Cardiovascular PREVention: Randomized Controlled Pilot Trial and Multidisciplinary Evaluation for National Health Service Implementation

Run by Catholic University of the Sacred Heart · NCT06911294 · Data updated 2026-11-12

This study is testing if using genetic information and smartwatches can help people make healthier choices to prevent heart disease.

Quick facts

Study typeInterventional
Ages40 Years to 69 Years
SexAll
Enrollment120 (estimated)
SponsorCatholic University of the Sacred Heart
Academic / other
Locations7 sites (Rome, Italy and 6 other locations)
StatusRecruiting
StartedFebruary 10, 2025
Main results expectedFebruary 10, 2026
Study endsSeptember 10, 2026
Registry record updatedAugust 5, 2025
Trial IDNCT06911294 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 40-69 with a 10-year cardiovascular risk score between 2.5% and 10% and a diagnosis of metabolic syndrome.

Probably not a fit

Patients with diabetes, familial hypercholesterolemia, or a history of cardiovascular events may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the feasibility of using innovative methods, such as Polygenic Risk Scores and health smartwatches, for personalized primary prevention of cardiovascular diseases. Participants will be randomized into four groups: standard care, genetic testing, digital intervention with a wearable device, or a combination of both. The study will assess the effectiveness of these interventions in promoting healthier lifestyle behaviors in a realistic setting, specifically within general practitioners' offices. The trial will last for 12 months, with key assessments at baseline, one month, six months, and twelve months.

Why it matters

Potential benefit: If successful, this study could lead to more personalized and effective prevention strategies for coronary heart disease.

How similar studies have gone: Other studies have shown promise in using genetic risk scores and digital interventions for cardiovascular prevention, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 40-69 years;
* 10 year cardiovascular risk score SCORE2 between 2.5% and 10%.
* Diagnosis of metabolic syndrome according to the American Heart Association criteria , defined as the presence of three or more of the following:

  * Central or abdominal obesity, measured by waist circumference (greater than 40 inches - 102 cm in men and 35 inches - 89 cm in women).
  * Elevated triglycerides: levels equal to or greater than 150 mg/dL or use of medication for hypertriglyceridemia.
  * Low HDL cholesterol levels (less than 40 mg/dL in men and less than 50 mg/dL in women) or use of cholesterol-lowering medication.
  * Elevated blood pressure: systolic ≥130 mmHg or diastolic ≥85 mmHg, or use of antihypertensive medication.
  * Elevated fasting blood glucose: ≥100 mg/dL or use of glucose-lowering medication.

Exclusion Criteria:

* Diabetes:
* Familial hypercholesterolemia;
* Previous cardiovascular events.

Where it's running

  • Studio Antonaci
    Rome, Italy, Italy
    Recruiting
  • Studio Colletti
    Rome, Italy
    Recruiting
  • Studio Maggiori
    Rome, Italy
    Recruiting
  • Studio Mammucari
    Rome, Italy
    Recruiting
  • Studio Marra
    Rome, Italy
    Recruiting
  • Studio Paoletti
    Rome, Italy
    Recruiting
Show 1 more location
  • Studio Pasca
    Rome, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.